The Effect of Cardiovascular Medications on Disease-Related Outcomes in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis

Background: Multiple studies have revealed that idiopathic pulmonary fibrosis (IPF) patients are more at risk for cardiovascular diseases and that many IPF patients receive cardiovascular medications like statins, angiotensin-converting enzyme inhibitor (ACEI), angiotensin receptor blocker (ARB), an...

Full description

Saved in:
Bibliographic Details
Main Authors: Wan-Tong Zhang, Xu-Jie Wang, Chun-Miao Xue, Xin-Yu Ji, Lin Pan, Wei-Liang Weng, Qiu-Yan Li, Guo-Dong Hua, Bao-Chen Zhu
Format: article
Language:EN
Published: Frontiers Media S.A. 2021
Subjects:
Online Access:https://doaj.org/article/14a744fe9ea848a88dade8a878fb2cd9
Tags: Add Tag
No Tags, Be the first to tag this record!